US2021024974A1PendingUtilityA1
High-Throughput Cell-Based Screening Methodology For Evaluating Carbohydrate-Active Enzymes
Est. expiryJul 22, 2039(~13 yrs left)· nominal 20-yr term from priority
G01N 2333/90245C12Q 1/26G01N 33/6872
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure relates, in one aspect, to the discovery of a high throughput screening (HTS) method to rapidly screen for GH/GS variants that are generated using directed evolution techniques and that can significantly enhance glycosynthase catalytic activity or product specificity.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A method of determining if a protein has transglycosylase activity, the method comprising:
contacting the protein with an azido glycosyl donor and a glycosyl acceptor to form a system, and measuring any change in azide concentration in the system.
2 . The method of claim 1 , wherein the azido glycosyl donor is substituted with an azido group at an anomeric or non-anomeric carbon.
3 . The method of claim 1 , wherein the azide concentration of the system comprises an inorganic azide and an anomeric glycosyl azide species or a non-anomeric glycosyl azide species.
4 . The method of claim 1 , wherein the measuring step comprises contacting the system with a reagent comprising a strained alkyne coupled to a dye, under conditions that allow for reaction of the strained alkyne with any azide or azido compound present in the system.
5 . The method of claim 4 , wherein the reagent comprises bicyclo[6.1.0]nonyne (BCN), dibenzocyclooctyne (DBCO), or any other strained alkyne.
6 . The method of claim 4 , wherein the reagent comprises 5-carboxytetramethylrhodamine (5-TAMRA), 6-carboxytetramethylrhodamine (6-TAMRA), or any combinations thereof.
7 . The method of claim 4 , wherein the strained alkyne and the dye are covalently linked by a linker in the reagent.
8 . The method of claim 7 , wherein the linker comprises a polyethylene glycol linker.
9 . The method of claim 1 , wherein the measuring step uses as a control a protein that has no measurable transglycosylase activity or has a known transglycosylase activity.
10 . The method of claim 1 , wherein the protein is a mutated glycosyl hydrolase (GH).
11 . The method of claim 1 , wherein the protein is expressed in a cell.
12 . The method of claim 11 , wherein the cell comprises E. coli or Pichia pastoris.
13 . The method of claim 11 , wherein the system is within the cell (intracellular).
14 . The method of claim 4 , wherein the measuring step comprises monitoring fluorescence of the system.
15 . The method of claim 13 , wherein fluorescence activated cell sorting (FACS) is used to separate individual cells by measured fluorescence.
16 . The method of claim 15 , which is configured for high-throughput screening.
17 . A polypeptide comprising an amino acid sequence of SEQ ID NO:1,
wherein the polypeptide comprises the mutation D224G (SEQ ID NO:2) with respect to SEQ ID NO:1, wherein the polypeptide further comprises at least one additional mutation selected from the group consisting of L15K, N70D, A366V, T392S, K395N, D400A, T413P, I428T, and T429P.
18 . The polypeptide of claim 17 , wherein the at least one additional mutation to an amino acid sequence of SEQ ID NO:2 is selected from the group consisting of: L15K-N70D; N70D-T392S; N70D-T392S-A366V-K395N; N70D-T392S-D400A; N70D-T392S-I428T; N70D-D400A-T413P-T429P.
19 . The polypeptide of claim 18 , which is selected from the group consisting of SEQ ID NOs:3-8.Join the waitlist — get patent alerts
Track US2021024974A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.